O. Oberschmidt

发表

Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment

U. Koehl, S. Kloess, O. Oberschmidt, 2017, Front. Immunol..

Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments

M. Lahn, A. Hanauske, O. Oberschmidt, 2007, Investigational New Drugs.

Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.

A. Schambach, S. Klöss, L. Arseniev, 2017, Human gene therapy.

Identification of a putative cation transporter gene from sugar beet (Beta vulgaris L.) by DDRT-PCR closely linked to the beet cyst nematode resistance gene Hs1pro-1

F. Grundler, M. Kleine, O. Oberschmidt, 2003 .

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

C. von Kalle, A. Ganser, R. Blasczyk, 2015, Journal of Translational Medicine.

In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression

H. Pospisil, S. Hoffmann, P. Paoletti, 2007, Investigational New Drugs.

Diurnal Lhc gene expression is present in many but not all species of the plant kingdom

B. Piechulla, O. Oberschmidt, Cornelia Hücking, 2004, Plant Molecular Biology.

Enzastaurin and pemetrexed exert synergistic antitumor activity in thyroid cancer cell lines in vitro.

D. Ma, M. Lahn, A. Hanauske, 2005, International journal of clinical pharmacology and therapeutics.

Pemetrexed: Target gene expression in human solid tumors correlates with chemosensitivity patterns.

P. Paoletti, D. Ma, M. Lahn, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering

A. Schambach, L. Arseniev, U. Koehl, 2019, Human gene therapy methods.

Antiproliferative activity of Titanocene Y against tumor colony-forming units

A. Hanauske, O. Oberschmidt, M. Tacke, 2007, Anti-cancer drugs.

Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice

P. Beckhove, V. Schirrmacher, A. Hanauske, 2007, Anti-cancer drugs.

Activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride against tumor colony-forming units

A. Hanauske, O. Oberschmidt, M. Tacke, 2005, Anti-cancer drugs.

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

A. Schambach, M. Heuser, Johann Meyer, 2019, Human gene therapy.

Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells

H. Pospisil, D. Ma, M. Lahn, 2008, Investigational New Drugs.

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

C. von Kalle, A. Ganser, R. Blasczyk, 2015, Journal of Translational Medicine.

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset

M. Heuser, L. Arseniev, U. Köhl, 2017, Front. Immunol..

Thymidylate synthase gene expression in solid tumors predicts for response to pemetrexed in vitro.

D. Ma, A. Hanauske, J. Blatter, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.

A. Schambach, S. Klöss, L. Arseniev, 2017, Human gene therapy.

Pemetrexed: mRNA expression of the target genes TS, GARFT and DHFR correlates with the in vitro chemosensitivity of human solid tumors.

C. Niyikiza, D. Ma, J. Blatter, 2005, International journal of clinical pharmacology and therapeutics.